Search

Author/Creator Bengrine-Lefèvre, Leila

1. FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial. (July 2019)

Authors:
Malka, David; François, Eric; Penault-Llorca, Frédérique; Castan, Florence; Bouché, Olivier; Bennouna, Jaafar; Ghiringhelli, François; de la Fouchardière, Christelle; Borg, Christophe; Samalin, Emmanuelle; Bachet, Jean-Baptiste; Raoul, Jean-Luc; Miglianico, Laurent; Bengrine-Lefèvre, Leila; Dahan...
Journal:
European journal of cancer
Issue:
Volume 115(2019)
Page Start:
97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search